Confirmed with Amboss, but Amboss lists B-blockers, nitrazine, and ranolazine as 2nd line agents (all highlighted as key info), so could add them to card somewhere? Could change the card to:
What drug classes are used for chronic stable angina?
1st line: {{c1::B-blockers}}
2nd line: {{c1::non-dihydropyridine CCBs}}, nitrates, and ranolazine
@Ahmed7 @herstein.jacob @Sameem @Cameron
Would prefer moving ccb to extra, B-blockers have additional benefit of preventing remodelling which ccbs lack
Is 2nd-line ever tested? #AK_Step2_v12::#UWorld::4127 if not can just move to extra @herstein.jacob
4127 asks about mechanism of most likely rx for patient with angina… so you need to know that BBs are first-line + mechanism of reducing anginal sx.
Also, nid:1551559303553 directly asks about non-dihydropyridine CCBs as alternative to beta blockers - I would say that this change is warranted, but clean up alternatives in extra